MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) has released an update.
HEALWELL AI’s advanced Clinical Co-Pilot technology has demonstrated its effectiveness in improving Chronic Kidney Disease (CKD) patient care in research published in the American Journal of Kidney Diseases. The AI tool, which integrates with Electronic Health Records, has been shown to enhance guideline-recommended testing for CKD patients, affirming the company’s role in addressing the significant health and economic impact of chronic diseases in North America. This innovation comes alongside the launch of WELL Health Technologies Corp.’s WELL AI Decision Support, which leverages HEALWELL’s technology to assist a wide network of healthcare providers.
For further insights into TSE:AIDX stock, check out TipRanks’ Stock Analysis page.
